Illumina 测序组合试剂盒 RS-304-1002

Illumina 测序组合试剂盒 RS-304-1002

Illumina/TruSight RNA Fusion Panel Set A (48 samples)/RS-304-1002/1 Ea

Illumina公司，致力于新一代测序和芯片技术的生产与开发，提供产品与应用资讯

Illumina公司创立于1998年4月，是遗传变异和生物学功能分析领域的优秀的产品、技术和服务供应商。通过帮助客户加快实现生物信息的采集、分析和应用，来改善人类健康。

Sequencing Kits/ Microarray Kits/Informatics Products/ Clinical Research Products/In Vitro Diagnostic/ Products/Molecular Biology Reagents/ Accessory Products

上海易汇生物科技有限公司于17年正式代理Illumina公司基因芯片、二代测序NGS测序仪及相关测序试剂盒等产品

咨询illumina MiSeq测序试剂盒等产品欢迎您致电 上海易汇生物科技有限公司：1850 1609 238张经理

Illumina/TruSight RNA Fusion Panel Set A (48 samples)/RS-304-1002/1 Ea RS-304-1002 Illumina 产品编号： RS-304-1002美  元  价： $0.00会  员  价： 待定品       牌： Illumina产       地： 美国公       司： Illumina, Inc.产品分类： 其它>其它试剂>芯片公司分类： Clinical Research Products "Product Highlights:

This targeted RNA sequencing panel is a cost-effective solution to detect gene fusions in multiple cancer types, regardless of origin. Covering 507 fusion-associated genes, a single assay enables researchers to assess most known cancer-related fusions in blood, bone marrow, and FFPE samples, with the power to identify novel fusion gene partners.

Industry-validated content for a comprehensive view of cancer-related fusion genes, detecting common and novel fusions

From RNA to results in 4 days including on-instrument software that displays fusion calls

Compatibility with desktop sequencers to maximize lab budgets

Optimized RNA sequencing for all sample types, including FFPE tissues

Simple Fusion Report for Customers New to NGS

On-instrument fusion calling provides NGS-based fusion detection to labs without additional bioinformatics support. The analysis provides a list of detected fusions, relevant disease associations (as identified by the Mitelman database), and evidence of fusion-supporting reads.

Robust, ReproducIBLe, and Low-Input Fusion Assay

This assay accommodates as little input as 20 ng FFPE RNA or 10 ng fresh-frozen total RNA. The TruSight RNA Fusion Panel provides a sensitive, reproducIBLe, and economical solution for studies of gene fusions in cancer research.

Specifications:

Assay Time 2.5 days

Hands-On Time 11 hours

Input Quantity 10 ng total RNA, 20–100 ng FFPE RNA

System Compatibility MiSeq,NextSeq 550,MiSeqDx in Research Mode,MiniSeq,NextSeq 500

Method Targeted RNA Sequencing,Sequencing for Cytogenomics

Variant Class Gene Fusions

Specialized Sample Types FFPE,Low Input

Technology Sequencing

Species Category Human

Cancer Type Pan-Cancer"

Illumina 测序组合试剂盒 RS-304-1002